{"entity":{"type":"insider","cik":"0001967163","url":"/insider/0001967163","json_url":"/insider/0001967163.json","name":"Patel Anish","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":26,"first":"2023-12-27","last":"2026-01-13","span_basis":"filed_date"},"name_variants":[{"name":"Patel Anish","source":"filing","n_filings":26,"first_seen":"2023-12-27","last_seen":"2026-01-13"}],"transactions":[{"id":5830420,"accession":"0001967163-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001967163-26-000001","line_url":"/filing/0001967163-26-000001","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48300.0,"shares_display":"48,300","price_per_share":27.98679501863354,"price_display":"27.99","price_state":"stated","total_value":1351762.1994,"total_display":"1,351,762.20","total_whole":"1,351,762","shares_owned_after":215254.0,"shares_owned_after_display":"215,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider","n_lines":2},{"id":4780598,"accession":"0001967163-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001967163-25-000005","line_url":"/filing/0001967163-25-000005","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6663.0,"shares_display":"6,663","price_per_share":21.022492060633347,"price_display":"21.02","price_state":"stated","total_value":140072.8646,"total_display":"140,072.86","total_whole":"140,073","shares_owned_after":265016.0,"shares_owned_after_display":"265,016","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":2},{"id":4054341,"accession":"0001967163-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001967163-25-000004","line_url":"/filing/0001967163-25-000004","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":17.404253562321884,"price_display":"17.40","price_state":"stated","total_value":116034.1585,"total_display":"116,034.16","total_whole":"116,034","shares_owned_after":270587.0,"shares_owned_after_display":"270,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-07","filed_date":"2025-11-12","scope":"insider","n_lines":2},{"id":4286078,"accession":"0001967163-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001967163-25-000003","line_url":"/filing/0001967163-25-000003#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":20.0979,"price_display":"20.10","price_state":"stated","total_value":133992.6993,"total_display":"133,992.70","total_whole":"133,993","shares_owned_after":276641.0,"shares_owned_after_display":"276,641","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-09","scope":"insider"},{"id":5155377,"accession":"0001415889-25-024196","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-024196","line_url":"/filing/0001415889-25-024196#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":20.2426,"price_display":"20.24","price_state":"stated","total_value":134957.4142,"total_display":"134,957.41","total_whole":"134,957","shares_owned_after":283308.0,"shares_owned_after_display":"283,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-08","filed_date":"2025-09-10","scope":"insider"},{"id":4641845,"accession":"0001415889-25-021456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021456","line_url":"/filing/0001415889-25-021456","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":18.241415374231288,"price_display":"18.24","price_state":"stated","total_value":121615.5163,"total_display":"121,615.52","total_whole":"121,616","shares_owned_after":290380.0,"shares_owned_after_display":"290,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-08-11","scope":"insider","n_lines":2},{"id":4434218,"accession":"0001415889-25-019609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019609","line_url":"/filing/0001415889-25-019609","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":19.7916002099895,"price_display":"19.79","price_state":"stated","total_value":131950.5986,"total_display":"131,950.60","total_whole":"131,951","shares_owned_after":296947.0,"shares_owned_after_display":"296,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-07","filed_date":"2025-07-09","scope":"insider","n_lines":2},{"id":4036520,"accession":"0001415889-25-016734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-016734","line_url":"/filing/0001415889-25-016734","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":20.335091225438727,"price_display":"20.34","price_state":"stated","total_value":135574.0532,"total_display":"135,574.05","total_whole":"135,574","shares_owned_after":303369.0,"shares_owned_after_display":"303,369","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-09","filed_date":"2025-06-11","scope":"insider","n_lines":2},{"id":4467113,"accession":"0001415889-25-012591","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-012591","line_url":"/filing/0001415889-25-012591","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":18.385909149542524,"price_display":"18.39","price_state":"stated","total_value":122578.8563,"total_display":"122,578.86","total_whole":"122,579","shares_owned_after":310470.0,"shares_owned_after_display":"310,470","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider","n_lines":3},{"id":4050884,"accession":"0001415889-25-010474","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-010474","line_url":"/filing/0001415889-25-010474","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":18.03940737963102,"price_display":"18.04","price_state":"stated","total_value":120268.729,"total_display":"120,268.73","total_whole":"120,269","shares_owned_after":319554.0,"shares_owned_after_display":"319,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-09","scope":"insider","n_lines":3},{"id":4357834,"accession":"0001415889-25-007683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007683","line_url":"/filing/0001415889-25-007683#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":21.4394,"price_display":"21.44","price_state":"stated","total_value":142936.4798,"total_display":"142,936.48","total_whole":"142,936","shares_owned_after":323310.0,"shares_owned_after_display":"323,310","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-11","scope":"insider"},{"id":4318212,"accession":"0001415889-25-003515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-003515","line_url":"/filing/0001415889-25-003515#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6667.0,"shares_display":"6,667","price_per_share":21.9298,"price_display":"21.93","price_state":"stated","total_value":146205.9766,"total_display":"146,205.98","total_whole":"146,206","shares_owned_after":329977.0,"shares_owned_after_display":"329,977","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-07","filed_date":"2025-02-10","scope":"insider"},{"id":5037848,"accession":"0001415889-25-001301","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-25-001301","line_url":"/filing/0001415889-25-001301","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28367.0,"shares_display":"28,367","price_per_share":24.17839194134029,"price_display":"24.18","price_state":"stated","total_value":685868.4442,"total_display":"685,868.44","total_whole":"685,868","shares_owned_after":1440.0,"shares_owned_after_display":"1,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider","n_lines":4},{"id":2486319,"accession":"0001415889-24-025505","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-025505","line_url":"/filing/0001415889-24-025505#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":716.0,"shares_display":"716","price_per_share":30.0035,"price_display":"30.00","price_state":"stated","total_value":21482.506,"total_display":"21,482.51","total_whole":"21,483","shares_owned_after":343311.0,"shares_owned_after_display":"343,311","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":2156201,"accession":"0001415889-24-019600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-019600","line_url":"/filing/0001415889-24-019600#line-3","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1547.0,"shares_display":"1,547","price_per_share":25.0111,"price_display":"25.01","price_state":"stated","total_value":38692.1717,"total_display":"38,692.17","total_whole":"38,692","shares_owned_after":344027.0,"shares_owned_after_display":"344,027","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-16","scope":"insider"},{"id":2156198,"accession":"0001415889-24-019600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019600","line_url":"/filing/0001415889-24-019600#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30978.0,"shares_display":"30,978","price_per_share":25.0513,"price_display":"25.05","price_state":"stated","total_value":776039.1714,"total_display":"776,039.17","total_whole":"776,039","shares_owned_after":345574.0,"shares_owned_after_display":"345,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-16","scope":"insider"},{"id":2156193,"accession":"0001415889-24-019600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019600","line_url":"/filing/0001415889-24-019600#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17475.0,"shares_display":"17,475","price_per_share":25.0698,"price_display":"25.07","price_state":"stated","total_value":438094.755,"total_display":"438,094.76","total_whole":"438,095","shares_owned_after":376552.0,"shares_owned_after_display":"376,552","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":3085964,"accession":"0001415889-24-016279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-016279","line_url":"/filing/0001415889-24-016279#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1133.0,"shares_display":"1,133","price_per_share":20.0551,"price_display":"20.06","price_state":"stated","total_value":22722.4283,"total_display":"22,722.43","total_whole":"22,722","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2024-06-10","scope":"insider"},{"id":2563753,"accession":"0001415889-24-013383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013383","line_url":"/filing/0001415889-24-013383#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1107.0,"shares_display":"1,107","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":27675.0,"total_display":"27,675.00","total_whole":"27,675","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2929262,"accession":"0001415889-24-013071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-013071","line_url":"/filing/0001415889-24-013071#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":25.0596,"price_display":"25.06","price_state":"stated","total_value":6515.496,"total_display":"6,515.50","total_whole":"6,515","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-09","filed_date":"2024-05-13","scope":"insider"},{"id":2999680,"accession":"0001415889-24-012652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012652","line_url":"/filing/0001415889-24-012652#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":22.7219,"price_display":"22.72","price_state":"stated","total_value":110769.2625,"total_display":"110,769.26","total_whole":"110,769","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider"},{"id":2043463,"accession":"0001415889-24-010831","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010831","line_url":"/filing/0001415889-24-010831#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":25.0342,"price_display":"25.03","price_state":"stated","total_value":438098.5,"total_display":"438,098.50","total_whole":"438,099","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-11","filed_date":"2024-04-15","scope":"insider"},{"id":2155666,"accession":"0001415889-24-010676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010676","line_url":"/filing/0001415889-24-010676","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":18.602417456410258,"price_display":"18.60","price_state":"stated","total_value":90686.7851,"total_display":"90,686.79","total_whole":"90,687","shares_owned_after":3141.0,"shares_owned_after_display":"3,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-10","scope":"insider","n_lines":2},{"id":2743792,"accession":"0001415889-24-007457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007457","line_url":"/filing/0001415889-24-007457#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":15.6387,"price_display":"15.64","price_state":"stated","total_value":76238.6625,"total_display":"76,238.66","total_whole":"76,239","shares_owned_after":7472.0,"shares_owned_after_display":"7,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-06","filed_date":"2024-03-08","scope":"insider"},{"id":2856284,"accession":"0001415889-24-003122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-003122","line_url":"/filing/0001415889-24-003122#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (CHIEF OPERATING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF OPERATING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF OPERATING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":15.1094,"price_display":"15.11","price_state":"stated","total_value":73658.325,"total_display":"73,658.32","total_whole":"73,658","shares_owned_after":12347.0,"shares_owned_after_display":"12,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2793490,"accession":"0001209191-24-002190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002190","line_url":"/filing/0001209191-24-002190#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4875.0,"shares_display":"4,875","price_per_share":15.135,"price_display":"15.14","price_state":"stated","total_value":73783.125,"total_display":"73,783.12","total_whole":"73,783","shares_owned_after":17222.0,"shares_owned_after_display":"17,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-24","scope":"insider"},{"id":2178277,"accession":"0001209191-24-000256","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-000256","line_url":"/filing/0001209191-24-000256#line-3","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":15.0048,"price_display":"15.00","price_state":"stated","total_value":165052.8,"total_display":"165,052.80","total_whole":"165,053","shares_owned_after":22097.0,"shares_owned_after_display":"22,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-02","scope":"insider"},{"id":2178274,"accession":"0001209191-24-000256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000256","line_url":"/filing/0001209191-24-000256#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20.0,"shares_display":"20","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":300.0,"total_display":"300.00","total_whole":"300","shares_owned_after":33097.0,"shares_owned_after_display":"33,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2024-01-02","scope":"insider"},{"id":2178271,"accession":"0001209191-24-000256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-000256","line_url":"/filing/0001209191-24-000256#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2520.0,"shares_display":"2,520","price_per_share":15.0776,"price_display":"15.08","price_state":"stated","total_value":37995.552,"total_display":"37,995.55","total_whole":"37,996","shares_owned_after":33117.0,"shares_owned_after_display":"33,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-28","filed_date":"2024-01-02","scope":"insider"},{"id":8045033,"accession":"0001209191-23-059816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059816","line_url":"/filing/0001209191-23-059816#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102.0,"shares_display":"102","price_per_share":15.005,"price_display":"15.00","price_state":"stated","total_value":1530.51,"total_display":"1,530.51","total_whole":"1,531","shares_owned_after":35637.0,"shares_owned_after_display":"35,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-27","scope":"insider"},{"id":8045027,"accession":"0001209191-23-059816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059816","line_url":"/filing/0001209191-23-059816#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001967163","owner_name":"Patel Anish","owner_display_name":"Patel Anish","owner_url":"/insider/0001967163","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":983.0,"shares_display":"983","price_per_share":15.0313,"price_display":"15.03","price_state":"stated","total_value":14775.7679,"total_display":"14,775.77","total_whole":"14,776","shares_owned_after":35739.0,"shares_owned_after_display":"35,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-22","filed_date":"2023-12-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":45,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Officer (CHIEF OPERATING OFFICER)","n_filings":26,"first_seen":"2023-12-27","last_seen":"2026-01-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001967163","retrieved_at":"2026-08-24T22:38:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}